In 2014, the Farm Bill, regarded as a monumental step towards the legalization of hemp and marijuana, opened the door for the Hemp Research Pilot Program. The program would allow for hemp cultivation for research purposes, kickstarting a budding multi-billion-dollar industry. The 2018 Farm Bill expanded on the provisions offered by the 2014 Farm Bill, […]

A Phase 2, globally sited clinical trial evaluating the potential efficacy of a promising brain cancer drug candidate against deadly glioblastoma (“GBM”) tumors is proceeding apace with a variety of patient profiles, affirming the drug developer’s confidence in its product.  In a Dec. 8 news release, CNS Pharmaceuticals (NASDAQ: CNSP) reported that 67 patients have […]

In spite of outside pressures on the cannabis sector, some analysts are predicting a reversal in the trend during the coming months (https://ibn.fm/NDYRj), and the most resourceful companies are continuing to build income channels amid the slowdown. International cannabis cultivator, Flora Growth (NASDAQ: FLGC) has boosted its YOY revenues more than five fold since Q3 […]

One of the main concerns associated with marketed drugs is low bioavailability. Bioavailability is the amount of a drug or substance that becomes completely available to the intended biological destination and is a measure of the rate and fraction of the initial dose of the drug that successfully reaches either the site of action or […]

Hillcrest Energy Technologies (CSE: HEAT) (OTCQB: HLRTF) has announced that the Company is accelerating its developmental efforts focused on grid-tied power conversion technologies as it completes the first Zero Voltage Switching (“ZVS”) inverter commercial prototype (https://ibn.fm/2FiVp). This clean technology developer of transformative power conversion technologies and control system solutions for modern electrical systems, expects the […]

Medical patient location device developer MetAlert (OTC: MLRT) is launching a suite of wearable companion products to its innovative SmartSole shoe insole units and, on the heels of rebranding the company to better represent its strategic direction, recently announced that it has engaged financial advisory firm Joseph Gunnar & Co., LLC to guide its financing […]

According to the National Renewable Energy Laboratory, buildings are the largest consumers of energy and one of the largest sources of greenhouse gas (“GHG”) emissions in the United States. They account for 70% of electricity use and about 40% of total primary energy consumption in the country. In 2020, carbon dioxide (“CO2”) from energy use […]

In the weeks leading up to August 2019, matters were tense at Meta (previously Facebook). A security hack had exposed personal information on over 533 million Facebook users spread across 106 countries. The social media company subsequently revealed that it had discovered and fixed the issue in August 2019, expressing confidence that the same route […]

CNS Pharmaceuticals (NASDAQ: CNSP) CEO John Climaco recently participated in the Virtual Investor “Ask the CEO” Event held December 6. As part of the virtual event, Climaco discussed his and the company’s background, provided an update on recent key events and plans for the 2023 calendar year, and assuaged investors’ concerns regarding the recent reverse […]

Throughout most of 2022, mortgage rates were rising due to the Federal Reserve’s increased interest rates to counter soaring inflation. However, mortgage rates have started dropping in recent weeks, reporting a downward trend for the fifth consecutive week. According to Freddie Mac, the 30-year fixed-rate mortgage averaged 6.31% in the week ending December 15, down […]